TGFB1 and Hyperglycemia: The hyperglycemia-induced increased TGF-β is suppressed by ERK1/2 inhibitor U0126, suggesting that ERK1/2 mediates upregulation of TGF-β, closely related to cardiomyocyte fibrosis [26].